These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
75 related items for PubMed ID: 1831460
1. The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. Takizawa S, Hogan M, Hakim AM. J Cereb Blood Flow Metab; 1991 Sep; 11(5):786-93. PubMed ID: 1831460 [Abstract] [Full Text] [Related]
2. Cerebral acidosis in focal ischemia: II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat. Hakim AM. J Cereb Blood Flow Metab; 1986 Dec; 6(6):676-83. PubMed ID: 3793803 [Abstract] [Full Text] [Related]
4. Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat. Park CK, Nehls DG, Teasdale GM, McCulloch J. J Cereb Blood Flow Metab; 1989 Oct; 9(5):617-22. PubMed ID: 2674169 [Abstract] [Full Text] [Related]
5. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]. Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R. Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678 [Abstract] [Full Text] [Related]
6. In vitro binding of [3H]nimodipine and [3H]CGS-19755 to rat brain in focal cerebral ischemia. Hogan MJ, Takizawa S, Hakim AM. Exp Neurol; 1995 Jul 19; 134(1):56-63. PubMed ID: 7672038 [Abstract] [Full Text] [Related]
7. Cerebral acidosis in focal ischemia: I. A method for the simultaneous measurement of local cerebral pH with cerebral glucose utilization or cerebral blood flow in the rat. Hakim AM, Arrieta M. J Cereb Blood Flow Metab; 1986 Dec 19; 6(6):667-75. PubMed ID: 3793802 [Abstract] [Full Text] [Related]
8. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia. Sauer D, Allegrini PR, Fagg GE. J Neural Transm Suppl; 1994 Dec 19; 43():81-9. PubMed ID: 7884410 [Abstract] [Full Text] [Related]
9. Increased cerebral oxygen consumption in Eker rats and effects of N-methyl-D-aspartate blockade: Implications for autism. Weiss HR, Liu X, Zhang Q, Chi OZ. J Neurosci Res; 2007 Aug 15; 85(11):2512-7. PubMed ID: 17549750 [Abstract] [Full Text] [Related]
10. The competitive NMDA antagonist, CGS-19755, improves postischemic hypoperfusion in selectively vulnerable regions in gerbils. Omae T, Hasegawa Y, Ogata J, Tamaki K, Minematsu K, Yamaguchi T. J Neurol Sci; 1996 Jun 15; 138(1-2):105-13. PubMed ID: 8791247 [Abstract] [Full Text] [Related]
11. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats. Okada M, Fujimura Y, Ueda H, Kometani M, Nakao K, Inukai T. Arzneimittelforschung; 1997 Feb 15; 47(2):115-9. PubMed ID: 9079228 [Abstract] [Full Text] [Related]
12. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia. Stevens MK, Yaksh TL. J Cereb Blood Flow Metab; 1990 Jan 15; 10(1):77-88. PubMed ID: 2153692 [Abstract] [Full Text] [Related]
13. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. Bennett DA, Bernard PS, Amrick CL, Wilson DE, Liebman JM, Hutchison AJ. J Pharmacol Exp Ther; 1989 Aug 15; 250(2):454-60. PubMed ID: 2547931 [Abstract] [Full Text] [Related]
14. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia. Pérez-Pinzón MA, Maier CM, Yoon EJ, Sun GH, Giffard RG, Steinberg GK. J Cereb Blood Flow Metab; 1995 Sep 15; 15(5):865-76. PubMed ID: 7673380 [Abstract] [Full Text] [Related]
15. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia. Lumenta DB, Plesnila N, Kläsner B, Baethmann A, Pruneau D, Schmid-Elsaesser R, Zausinger S. Brain Res; 2006 Jan 19; 1069(1):227-34. PubMed ID: 16378603 [Abstract] [Full Text] [Related]
16. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat. Okada M, Ueda H, Kometani M, Nakao K. Arzneimittelforschung; 1997 Jun 19; 47(6):703-5. PubMed ID: 9239446 [Abstract] [Full Text] [Related]
17. In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia. Hogan MJ, Gjedde A, Hakim AM. J Neurochem; 1992 Jan 19; 58(1):186-91. PubMed ID: 1727429 [Abstract] [Full Text] [Related]
18. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat. Sharkey J, Ritchie IM, Butcher SP, Kelly JS. Brain Res; 1994 Jul 18; 651(1-2):27-36. PubMed ID: 7922575 [Abstract] [Full Text] [Related]
19. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. Steinberg GK, Kunis D, Saleh J, DeLaPaz R. J Cereb Blood Flow Metab; 1991 Nov 18; 11(6):1015-24. PubMed ID: 1939379 [Abstract] [Full Text] [Related]
20. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats. Zhang Y, Belayev L, Zhao W, Irving EA, Busto R, Ginsberg MD. Brain Res; 2005 May 31; 1045(1-2):150-6. PubMed ID: 15910773 [Abstract] [Full Text] [Related] Page: [Next] [New Search]